Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)

Clinical trial NCT05862012 · RECRUITING

Trial details

NCT number: NCT05862012
Sponsor: Ichnos Sciences SA
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed/Refractory Multiple Myeloma

Start date: 2023-11-01
Primary completion: 2027-07-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.